Preeclampsia has two phenotypes which require different treatment strategies
- PMID: 34774281
- DOI: 10.1016/j.ajog.2020.10.052
Preeclampsia has two phenotypes which require different treatment strategies
Abstract
The opinion on the mechanisms underlying the pathogenesis of preeclampsia still divides scientists and clinicians. This common complication of pregnancy has long been viewed as a disorder linked primarily to placental dysfunction, which is caused by abnormal trophoblast invasion, however, evidence from the previous two decades has triggered and supported a major shift in viewing preeclampsia as a condition that is caused by inherent maternal cardiovascular dysfunction, perhaps entirely independent of the placenta. In fact, abnormalities in the arterial and cardiac functions are evident from the early subclinical stages of preeclampsia and even before conception. Moving away from simply observing the peripheral blood pressure changes, studies on the central hemodynamics reveal two different mechanisms of cardiovascular dysfunction thought to be reflective of the early-onset and late-onset phenotypes of preeclampsia. More recent evidence identified that the underlying cardiovascular dysfunction in these phenotypes can be categorized according to the presence of coexisting fetal growth restriction instead of according to the gestational period at onset, the former being far more common at early gestational ages. The purpose of this review is to summarize the hemodynamic research observations for the two phenotypes of preeclampsia. We delineate the physiological hemodynamic changes that occur in normal pregnancy and those that are observed with the pathologic processes associated with preeclampsia. From this, we propose how the two phenotypes of preeclampsia could be managed to mitigate or redress the hemodynamic dysfunction, and we consider the implications for future research based on the current evidence. Maternal hemodynamic modifications throughout pregnancy can be recorded with simple-to-use, noninvasive devices in obstetrical settings, which require only basic training. This review includes a brief overview of the methodologies and techniques used to study hemodynamics and arterial function, specifically the noninvasive techniques that have been utilized in preeclampsia research.
Keywords: arterial function; blood pressure; cardiac output; cardiovascular function; fetal growth restriction; hemodynamics; hypertensive disease of pregnancy; preeclampsia; vascular resistance.
Copyright © 2020 Elsevier Inc. All rights reserved.
Comment in
-
Reply: Preeclampsia has 2 phenotypes that require different treatment strategies.Am J Obstet Gynecol. 2022 Jul;227(1):114-115. doi: 10.1016/j.ajog.2021.09.006. Epub 2021 Sep 14. Am J Obstet Gynecol. 2022. PMID: 34534502 No abstract available.
Similar articles
-
Early and late preeclampsia are characterized by high cardiac output, but in the presence of fetal growth restriction, cardiac output is low: insights from a prospective study.Am J Obstet Gynecol. 2018 May;218(5):517.e1-517.e12. doi: 10.1016/j.ajog.2018.02.007. Epub 2018 Feb 21. Am J Obstet Gynecol. 2018. PMID: 29474844
-
Hemodynamic pathways of gestational hypertension and preeclampsia.Am J Obstet Gynecol. 2022 Feb;226(2S):S988-S1005. doi: 10.1016/j.ajog.2021.11.022. Am J Obstet Gynecol. 2022. PMID: 35177225 Review.
-
An integrated model of preeclampsia: a multifaceted syndrome of the maternal cardiovascular-placental-fetal array.Am J Obstet Gynecol. 2022 Feb;226(2S):S963-S972. doi: 10.1016/j.ajog.2020.10.023. Epub 2021 Mar 9. Am J Obstet Gynecol. 2022. PMID: 33712272 Review.
-
Uterine and fetal placental Doppler indices are associated with maternal cardiovascular function.Am J Obstet Gynecol. 2019 Jan;220(1):96.e1-96.e8. doi: 10.1016/j.ajog.2018.09.017. Epub 2018 Sep 19. Am J Obstet Gynecol. 2019. PMID: 30243605
-
The "Preeclampsia and Hypertension Target Treatment" study: a multicenter prospective study to evaluate the effectiveness of the antihypertensive therapy based on maternal hemodynamic findings.Am J Obstet Gynecol MFM. 2024 May;6(5):101368. doi: 10.1016/j.ajogmf.2024.101368. Epub 2024 Apr 3. Am J Obstet Gynecol MFM. 2024. PMID: 38574856
Cited by
-
Obstetric antiphospholipid syndrome carries an increased lifetime risk for obstetric and thrombotic complications-a population-based study.Res Pract Thromb Haemost. 2024 Apr 29;8(4):102430. doi: 10.1016/j.rpth.2024.102430. eCollection 2024 May. Res Pract Thromb Haemost. 2024. PMID: 38798792 Free PMC article.
-
Klotho-mediated activation of the anti-oxidant Nrf2/ARE signal pathway affects cell apoptosis, senescence and mobility in hypoxic human trophoblasts: involvement of Klotho in the pathogenesis of preeclampsia.Cell Div. 2024 Apr 17;19(1):13. doi: 10.1186/s13008-024-00120-2. Cell Div. 2024. PMID: 38632651 Free PMC article.
-
Immunologic aspects of preeclampsia.AJOG Glob Rep. 2024 Feb 9;4(1):100321. doi: 10.1016/j.xagr.2024.100321. eCollection 2024 Feb. AJOG Glob Rep. 2024. PMID: 38586611 Free PMC article. Review.
-
Novel Associations Between Mid-Pregnancy Cardiovascular Biomarkers and Preeclampsia: An Explorative Nested Case-Control Study.Reprod Sci. 2024 May;31(5):1391-1400. doi: 10.1007/s43032-023-01445-z. Epub 2024 Jan 22. Reprod Sci. 2024. PMID: 38253981 Free PMC article.
-
Examining the Aryl Hydrocarbon Receptor Network in the Placental Tissues of Pregnancies Complicated by Pre-Eclampsia: An Explorative Case-Control Analysis.Life (Basel). 2023 Oct 26;13(11):2122. doi: 10.3390/life13112122. Life (Basel). 2023. PMID: 38004262 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical